건강증진 연구 보고지침

Reporting Guidelines for Health Promotion Research

  • 유승현 (서울대학교 보건대학원, 건강증진연구센터)
  • Yoo, Seung-Hyun (Seoul National University Graduate School of Public Health & Center for Health Promotion Research)
  • 투고 : 2012.09.01
  • 심사 : 2012.09.18
  • 발행 : 2012.10.01

초록

Objectives: The purpose of this review is to introduce reporting guidelines for health promotion research in an effort to enhance systematic structure and quality of health promotion research reported in academic papers. Methods: Widely accepted guidelines were selected for description, which focus on 4 distinct types of research design. Checklists and flow diagrams are described and compared. Results: CONSORT Statement is reporting guidelines for randomized controlled trials with a 25-item checklist and a flow diagram. TREND Statement with a 22-item checklist is to guide reporting of health research in nonrandomized design. STROBE Statement is a compiled guidelines for observational health research, accompanied by a 22-item checklist in a combined edition. PRISMA Statement consists of a 27-item checklist and a flow diagram, providing guidelines for reporting systematic reviews and meta-analyses. All items on the checklists and flow diagrams were introduced and discussed. Conclusion: Solid understanding of research designs and adoption of reporting guidelines will enhance the quality of research with information on internal and external validity. Education and training of researchers on the research reporting is required along with systems level adoption of efforts for research enhancement.

키워드

참고문헌

  1. Centers for Disease Control and Prevention. (2011). TREND supporters. Retrieved from http://www.cdc.gov/trendstatement/supporters.html
  2. CONSORT Group, The. (2012). CONSORT: Transparent reporting of trials. Retrieved from http://www.consort-statement.org
  3. Des Jarlais, D. C., Lyles, C., Crepaz, N., & the TREND Group. (2004). Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TERND Statement. American Journal of Public Health, 94, 361-366. https://doi.org/10.2105/AJPH.94.3.361
  4. Hartling, L., Bond, K., Harvey, K., Santaguida, P. L., Viswanathan, M., & Dryden, D. M. (2010). Developing and testing a tool for the classification of study design in systematic reviews of interventions and exposures. Rockville, MD: Agency for Healthcare Research and Quality.
  5. Korea Centers for Disease Control. (n.d.). About CRIS. Retrieved from cris.cdc.go.kr/cris/use_guide/cris_introduce.jsp
  6. Moher, D., Liberati, A., Tetziaff, J., Altman, D. G., & the PRISMA Group. (2009). Preferred Reporting Items for Systematic Reviews & Meta-Analysis: The PRISMA Statement. PLoS Med, 6(6), e1000097. doi:10.1371/journal.pmed1000097
  7. Moher, D., Weeks, L., Ocampo, M., Seely, D., Sampson, M., Altman, D. G., . . . Hoey, J. (2011). Describing reporting guidelines for health research: a systematic review. Journal of Clinical Epidemiology, 64, 718-742. https://doi.org/10.1016/j.jclinepi.2010.09.013
  8. National Institute for Clinical Excellence. (2004). Guideline development methods: Information for National Collaborating Centres and guideline developers. London: National Institue for Clinical Excellence
  9. National Library of Medicine. (n.d.). Understanding clinical trials. Retrieved from clinicaltrials.gov/ct2/info/understand
  10. PRISMA Group, The. (n.d.). PRISMA: Transparent reporting of systematic reviews and meta-analyses. Retrieved from www.prisma-statement.org
  11. Schulz, K. F., Altman, D. G., & Moher, D. (2010). CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. BMJ, 340, 698-702.
  12. STROBE Group, The. (2009). STROBE Statement: Strengthening the reporting of observational studies in epidemiology. Retrieved from www.strobe-statement.org